Medibank Private Limited (ASX:MPL)
Australia
· Delayed Price · Currency is AUD 4.510
+0.090 (2.04%)
Mar 28, 2025, 4:10 PM AEST
Medibank Private Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Premiums & Annuity Revenue | 7,818 | 7,623 | 7,086 | 6,881 | 6,691 | 6,555 | Upgrade
|
| Total Interest & Dividend Income | 175.8 | 164.3 | 108.2 | 55.9 | 51 | 54.6 | Upgrade
|
| Gain (Loss) on Sale of Investments | 40.1 | 19.5 | 30.4 | -80.7 | 69 | -52.2 | Upgrade
|
| Other Revenue | 301.6 | 222.8 | 173.3 | 248.3 | 221.1 | 222.3 | Upgrade
|
| Total Revenue | 8,335 | 8,030 | 7,398 | 7,105 | 7,032 | 6,779 | Upgrade
|
| Revenue Growth (YoY) | 6.21% | 8.53% | 4.13% | 1.03% | 3.73% | 0.21% | Upgrade
|
| Policy Benefits | 6,507 | 6,289 | 6,057 | 5,680 | 5,558 | 5,487 | Upgrade
|
| Depreciation & Amortization | - | - | - | 115 | 122 | 126.9 | Upgrade
|
| Selling, General & Administrative | 627.9 | 619.5 | 566.6 | 290.4 | 281.5 | 284.5 | Upgrade
|
| Other Operating Expenses | 471.4 | 396.7 | 333.5 | - | - | - | Upgrade
|
| Total Operating Expenses | 7,606 | 7,306 | 6,957 | 6,547 | 6,396 | 6,326 | Upgrade
|
| Operating Income | 729 | 724.2 | 441.1 | 557.9 | 636.1 | 453.6 | Upgrade
|
| Interest Expense | -6.6 | -5.4 | -1.8 | -2.4 | -2.8 | -3.4 | Upgrade
|
| Earnings From Equity Investments | -9.6 | -7.1 | -1.4 | 4.5 | -1 | - | Upgrade
|
| EBT Excluding Unusual Items | 712.8 | 711.7 | 437.9 | 560 | 632.3 | 450.2 | Upgrade
|
| Pretax Income | 712.8 | 711.7 | 437.9 | 560 | 632.3 | 450.2 | Upgrade
|
| Income Tax Expense | 215.5 | 215.3 | 129.3 | 166.1 | 191.1 | 134.6 | Upgrade
|
| Earnings From Continuing Ops. | 497.3 | 496.4 | 308.6 | 393.9 | 441.2 | 315.6 | Upgrade
|
| Earnings From Discontinued Ops. | - | - | - | - | - | -0.6 | Upgrade
|
| Net Income to Company | 497.3 | 496.4 | 308.6 | 393.9 | 441.2 | 315 | Upgrade
|
| Minority Interest in Earnings | -7.7 | -3.9 | - | - | - | - | Upgrade
|
| Net Income | 489.6 | 492.5 | 308.6 | 393.9 | 441.2 | 315 | Upgrade
|
| Net Income to Common | 489.6 | 492.5 | 308.6 | 393.9 | 441.2 | 315 | Upgrade
|
| Net Income Growth | 1.39% | 59.59% | -21.65% | -10.72% | 40.06% | -31.33% | Upgrade
|
| Shares Outstanding (Basic) | 2,753 | 2,754 | 2,754 | 2,754 | 2,754 | 2,754 | Upgrade
|
| Shares Outstanding (Diluted) | 2,753 | 2,754 | 2,754 | 2,754 | 2,754 | 2,754 | Upgrade
|
| EPS (Basic) | 0.18 | 0.18 | 0.11 | 0.14 | 0.16 | 0.11 | Upgrade
|
| EPS (Diluted) | 0.18 | 0.18 | 0.11 | 0.14 | 0.16 | 0.11 | Upgrade
|
| EPS Growth | 0.98% | 59.59% | -21.65% | -10.72% | 40.06% | -31.33% | Upgrade
|
| Free Cash Flow | 616.8 | 861.5 | 176.7 | 941.5 | 471.3 | 569.2 | Upgrade
|
| Free Cash Flow Per Share | 0.22 | 0.31 | 0.06 | 0.34 | 0.17 | 0.21 | Upgrade
|
| Dividend Per Share | 0.172 | 0.166 | 0.146 | 0.134 | 0.127 | 0.120 | Upgrade
|
| Dividend Growth | 10.97% | 13.70% | 8.96% | 5.51% | 5.83% | -8.40% | Upgrade
|
| Operating Margin | 8.75% | 9.02% | 5.96% | 7.85% | 9.05% | 6.69% | Upgrade
|
| Profit Margin | 5.87% | 6.13% | 4.17% | 5.54% | 6.27% | 4.65% | Upgrade
|
| Free Cash Flow Margin | 7.40% | 10.73% | 2.39% | 13.25% | 6.70% | 8.40% | Upgrade
|
| EBITDA | 752.3 | 738.1 | 454.2 | 571.2 | 654 | 475.8 | Upgrade
|
| EBITDA Margin | 9.03% | 9.19% | 6.14% | 8.04% | 9.30% | 7.02% | Upgrade
|
| D&A For EBITDA | 23.3 | 13.9 | 13.1 | 13.3 | 17.9 | 22.2 | Upgrade
|
| EBIT | 729 | 724.2 | 441.1 | 557.9 | 636.1 | 453.6 | Upgrade
|
| EBIT Margin | 8.75% | 9.02% | 5.96% | 7.85% | 9.05% | 6.69% | Upgrade
|
| Effective Tax Rate | 30.23% | 30.25% | 29.53% | 29.66% | 30.22% | 29.90% | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.